Paushak Limited (NSE:PAUSHAKLTD)
612.45
-2.15 (-0.35%)
At close: Nov 9, 2026
Paushak Revenue
Paushak had revenue of 893.20M INR in the quarter ending September 30, 2026, with 51.96% growth. This brings the company's total for the last twelve months to 2.77B, up 27.98% year-over-year. In the fiscal year ending March 31, 2026, Paushak had annual revenue of 2.19B with 3.63% growth.
Revenue (ttm)
2.77B
Revenue Growth
+27.98%
P/S Ratio
5.44
Revenue / Employee
7.54M
Employees
367
Market Cap
15.07B
Revenue by Geography
- India 1.79B 82.7%
- Outside India 376.57M 17.3%
Fiscal year ended Mar 31, 2026 See the full Paushak breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.19B | 76.52M | 3.63% |
| Mar 31, 2025 | 2.11B | 46.89M | 2.27% |
| Mar 31, 2024 | 2.06B | -60.85M | -2.87% |
| Mar 31, 2023 | 2.12B | 622.44M | 41.47% |
| Mar 31, 2022 | 1.50B | 91.02M | 6.46% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossari Biotech | 26.61B |
| S H Kelkar and Company | 25.31B |
| Veedol Corporation | 24.01B |
| Jubilant Agri and Consumer Products | 20.52B |
| NOCIL | 14.76B |
| Shree Pushkar Chemicals & Fertilisers | 11.52B |
| Jai Corp | 6.07B |
| Fairchem Organics | 5.60B |
Paushak News
- 7 months ago - India opens anti-dumping probe into ethyl chloroformate imports from China - The Times of India